Al Jazeera · 5 Nov 2026
Why Guinea-Bissau halted a controversial hepatitis vaccine trial for babies
Experts have said the US-funded trial would deny critical vaccines to thousands of infants. Guinea-Bissau has reportedly halted a controversial United States-funded hepatitis B virus vaccine (HBV) trial which drew global scrutiny when experts said it involved withholding lifesaving shots from thousands of babies.
⬅ Back home
Read full article ➡